About Vertex GPS

*Enrollment status is as of October 2022.

Personalized support for whatever's up next

No matter where life with cystic fibrosis (CF) takes you, we’re here to help you stay on track with your Vertex treatment. And whatever stage you’re at, we’ll keep in touch so we can meet your specific needs.

Over 20,000 patients have been a part of Vertex GPS

Since 2012, GPS has helped support people with CF along their treatment journey.

 

Individuals pictured may or may not be currently enrolled in Vertex GPS.

Ask about enrolling to get the support you need

If you haven’t enrolled in Vertex GPS yet, we can guide you through the process and help get your Vertex medicine shipped right to your door.

Here’s how it works:

STEP 1

Enrolling in the program

If you’re prescribed a Vertex medicine, you can ask your healthcare provider to complete an enrollment form on your behalf at any time—regardless of when you started treatment.

STEP 2

Connecting with your GPS Support Specialist

After you enroll, your dedicated Support Specialist will be in touch to learn about your needs and walk you through the next steps for getting your medicine.

STEP 3

Verifying your insurance coverage and reviewing financial assistance options

Your Support Specialist will confirm coverage and out-of-pocket costs with your insurance company and can review your eligibility for the Vertex GPS Co-pay Assistance Program.

STEP 4

Coordinating your shipments

After your insurance coverage is confirmed, your Support Specialist will coordinate shipments with the specialty pharmacy and send monthly refill reminders.

Limitations apply. Annual assistance is limited to a maximum of $20,000. Not available to individuals with government-funded insurance such as Medicaid, Medicare, and TRICARE®. Vertex reserves the right to rescind, revoke, or amend this assistance program at any time.

Represents individuals both currently and previously enrolled in Vertex GPS since 2012, regardless of whether they are now actively taking a Vertex medicine.